Importantly, many of the glycerolipids and glycerophospholipids have palmitic acid in their side chain, supporting the role of the GCKR variant in the pathogenesis of NAFLD via generation of malonyl-CoA and an increase in de novo lipogenesis [47]. This evidence concerns the gene GCKR and metabolic dysfunction-associated steatotic liver disease.